Matches in Wikidata for { <http://www.wikidata.org/entity/Q59284846> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- Q59284846 description "article scientifique publié en 2007" @default.
- Q59284846 description "artículu científicu espublizáu en febreru de 2007" @default.
- Q59284846 description "im Februar 2007 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59284846 description "scientific article published on 21 February 2007" @default.
- Q59284846 description "wetenschappelijk artikel" @default.
- Q59284846 description "наукова стаття, опублікована в березні 2007" @default.
- Q59284846 name "Eslicarbazepine Acetate: A Double-blind, Add-on, Placebo-controlled Exploratory Trial in Adult Patients with Partial-onset Seizures" @default.
- Q59284846 name "Eslicarbazepine Acetate: A Double-blind, Add-on, Placebo-controlled Exploratory Trial in Adult Patients with Partial-onset Seizures" @default.
- Q59284846 type Item @default.
- Q59284846 label "Eslicarbazepine Acetate: A Double-blind, Add-on, Placebo-controlled Exploratory Trial in Adult Patients with Partial-onset Seizures" @default.
- Q59284846 label "Eslicarbazepine Acetate: A Double-blind, Add-on, Placebo-controlled Exploratory Trial in Adult Patients with Partial-onset Seizures" @default.
- Q59284846 prefLabel "Eslicarbazepine Acetate: A Double-blind, Add-on, Placebo-controlled Exploratory Trial in Adult Patients with Partial-onset Seizures" @default.
- Q59284846 prefLabel "Eslicarbazepine Acetate: A Double-blind, Add-on, Placebo-controlled Exploratory Trial in Adult Patients with Partial-onset Seizures" @default.
- Q59284846 P1433 Q59284846-7E688408-2000-4EFF-AC56-9DA09832EFAB @default.
- Q59284846 P1476 Q59284846-DDB4586E-65EA-47F1-9B5A-4417959BE62A @default.
- Q59284846 P2093 Q59284846-1D331125-0ACD-438B-9327-77BF70EE4B97 @default.
- Q59284846 P2093 Q59284846-1DA36EBB-8D59-4C93-B28B-A647F97DE28F @default.
- Q59284846 P2093 Q59284846-94F0BD6B-9517-41C8-8A8B-829518384017 @default.
- Q59284846 P2093 Q59284846-F56B7F6C-5C6D-4215-8A30-539B2192E428 @default.
- Q59284846 P2860 Q59284846-0F57E6ED-B67C-4524-9A71-6FF4A7345FAC @default.
- Q59284846 P2860 Q59284846-28D90B78-B7EB-40EF-8D20-E3A68CC6D84B @default.
- Q59284846 P2860 Q59284846-29BE1732-641B-4E30-AC2B-7D79CA931650 @default.
- Q59284846 P2860 Q59284846-2A7B565B-DE49-451E-9FE6-0EA4728751F4 @default.
- Q59284846 P2860 Q59284846-2DF9FA29-F15B-45C2-A947-9B4CEE27B914 @default.
- Q59284846 P2860 Q59284846-37FF31C3-7EBF-4E12-A913-E35598243207 @default.
- Q59284846 P2860 Q59284846-5A7D11B7-6098-483E-B605-986CF3F56B2E @default.
- Q59284846 P2860 Q59284846-5F44C096-DA0A-4438-A2EC-F887C102E848 @default.
- Q59284846 P2860 Q59284846-61F841AA-BE32-4B55-BF12-BA36745538FD @default.
- Q59284846 P2860 Q59284846-BFBAE9CF-F5CF-4DF3-A936-A1209AFEC9D7 @default.
- Q59284846 P2860 Q59284846-C40A6B76-77EA-4958-A198-ED5CE4F1D241 @default.
- Q59284846 P2860 Q59284846-C7D326F1-A759-41F3-93B9-3CFE2D7CF6DB @default.
- Q59284846 P2860 Q59284846-FCB42144-BEF9-49B7-9465-9D75513CF66F @default.
- Q59284846 P2860 Q59284846-FEF82606-FAC6-4251-AEDB-D935AC12454C @default.
- Q59284846 P304 Q59284846-08DC04D3-B288-4DEA-88FE-3FCA98B6F4A7 @default.
- Q59284846 P31 Q59284846-9BDA35CD-2F16-436F-B91C-6C8EF575BD8B @default.
- Q59284846 P356 Q59284846-4D7906A9-28AE-4182-99BC-F84CA3688A59 @default.
- Q59284846 P433 Q59284846-1E875573-98B2-49A1-8B46-2BE74DE4B807 @default.
- Q59284846 P478 Q59284846-7FE7838C-1E39-4D1A-A9A9-BB9300F4BFB5 @default.
- Q59284846 P50 Q59284846-71B12EF2-EE27-4A13-86BB-EE5A74C6711F @default.
- Q59284846 P50 Q59284846-DBB1A70E-117A-4F44-9353-D0C68B689261 @default.
- Q59284846 P577 Q59284846-0EC64C52-7CA9-4436-AF85-6A3781781F24 @default.
- Q59284846 P698 Q59284846-D0F95AF4-1D0A-4D03-9F0A-387E68A3B930 @default.
- Q59284846 P921 Q59284846-4EB6EBEC-8737-485C-9B67-4F295DA4463D @default.
- Q59284846 P356 J.1528-1167.2007.00984.X @default.
- Q59284846 P698 17319919 @default.
- Q59284846 P1433 Q5382969 @default.
- Q59284846 P1476 "Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures" @default.
- Q59284846 P2093 "Christian Elger" @default.
- Q59284846 P2093 "Joana Maia" @default.
- Q59284846 P2093 "Joyce A Cramer" @default.
- Q59284846 P2093 "Meir Bialer" @default.
- Q59284846 P2860 Q28295675 @default.
- Q59284846 P2860 Q31133698 @default.
- Q59284846 P2860 Q34583101 @default.
- Q59284846 P2860 Q35124000 @default.
- Q59284846 P2860 Q40802622 @default.
- Q59284846 P2860 Q43588649 @default.
- Q59284846 P2860 Q43590389 @default.
- Q59284846 P2860 Q44571504 @default.
- Q59284846 P2860 Q45001572 @default.
- Q59284846 P2860 Q46578418 @default.
- Q59284846 P2860 Q46650441 @default.
- Q59284846 P2860 Q46674846 @default.
- Q59284846 P2860 Q46724538 @default.
- Q59284846 P2860 Q48159755 @default.
- Q59284846 P304 "497-504" @default.
- Q59284846 P31 Q13442814 @default.
- Q59284846 P356 "10.1111/J.1528-1167.2007.00984.X" @default.
- Q59284846 P433 "3" @default.
- Q59284846 P478 "48" @default.
- Q59284846 P50 Q37830793 @default.
- Q59284846 P50 Q42937867 @default.
- Q59284846 P577 "2007-02-21T00:00:00Z" @default.
- Q59284846 P698 "17319919" @default.
- Q59284846 P921 Q269829 @default.